Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Mail to Mr. West (analyst from Dutton)

"We know more now than we did then. 2 examples, we have more information on licensing and the overall economic climate is substantially different."

Of course we do, but if Dutton says, the company is in a better shape TODAY, it means, the development with all the relating events should be seen as positive and thus I can't understand, why he doesn't take at least his first price target of $1,12. This defies logic IMO.

GLTY



Share
New Message
Please login to post a reply